FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315435880> ?p ?o ?g. }

• W4315435880 endingPage "1775" @default.
• W4315435880 startingPage "1768" @default.
• W4315435880 abstract "Abstract Background Current US Food and Drug Administration guidance recommends that the primary endpoint for complicated urinary tract infection clinical trials be a composite of the clinical and microbiological responses, assessed at a fixed point after therapy. Although some participants meet the criteria for clinical success, they do not meet the criteria for microbiological eradication and are classified as treatment failures. These discordant outcomes have raised questions about the utility of the microbiological endpoint. Methods We analyzed participant data from 13 phase 3 clinical trials submitted to the US Food and Drug Administration (N = 4842). Outcomes were determined at the test of cure (TOC) visit, recommended to occur at least 5 days after therapy and at the late follow-up visit, recommended to occur 21 to 28 days after randomization. Clinical and microbiological success were defined as the resolution of complicated urinary tract infection symptoms present at study entry, with no new symptoms (clinical cure), and a reduction in density of the original pathogen to &lt;103 CFU/mL on urine culture (microbiological eradication). Results Among included participants, 70.7% were concordant successes at the TOC visit, 18.0% were discordant failures (clinical cure/microbiological persistence), and 6.7% were concordant failures (clinical failure/microbiological persistence). Discordant participants were at an increased risk for clinical failure at the late follow-up visit, and the risk of late clinical failure increased with time. Conclusions Discordant clinical and microbiological outcomes at the TOC visit were associated with an increased risk of late clinical failure. Microbiological outcomes appear to be an important component of the endpoint." @default.
• W4315435880 created "2023-01-11" @default.
• W4315435880 creator A5011245333 @default.
• W4315435880 creator A5034030812 @default.
• W4315435880 creator A5035781067 @default.
• W4315435880 creator A5043103500 @default.
• W4315435880 creator A5068186372 @default.
• W4315435880 date "2023-01-10" @default.
• W4315435880 modified "2023-10-13" @default.
• W4315435880 title "Discordant Clinical and Microbiological Outcomes Are Associated With Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections" @default.
• W4315435880 cites W1967046314 @default.
• W4315435880 cites W2001383451 @default.
• W4315435880 cites W2067191390 @default.
• W4315435880 cites W2129742068 @default.
• W4315435880 cites W2139168999 @default.
• W4315435880 cites W2144373793 @default.
• W4315435880 cites W2151082802 @default.
• W4315435880 cites W2528299860 @default.
• W4315435880 cites W2973738469 @default.
• W4315435880 cites W2999388668 @default.
• W4315435880 cites W3169556620 @default.
• W4315435880 cites W4304690344 @default.
• W4315435880 doi "https://doi.org/10.1093/cid/ciad010" @default.
• W4315435880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36625164" @default.
• W4315435880 hasPublicationYear "2023" @default.
• W4315435880 type Work @default.
• W4315435880 citedByCount "2" @default.
• W4315435880 countsByYear W43154358802023 @default.
• W4315435880 crossrefType "journal-article" @default.
• W4315435880 hasAuthorship W4315435880A5011245333 @default.
• W4315435880 hasAuthorship W4315435880A5034030812 @default.
• W4315435880 hasAuthorship W4315435880A5035781067 @default.
• W4315435880 hasAuthorship W4315435880A5043103500 @default.
• W4315435880 hasAuthorship W4315435880A5068186372 @default.
• W4315435880 hasBestOaLocation W43154358801 @default.
• W4315435880 hasConcept C126322002 @default.
• W4315435880 hasConcept C177713679 @default.
• W4315435880 hasConcept C203092338 @default.
• W4315435880 hasConcept C204243189 @default.
• W4315435880 hasConcept C3018890749 @default.
• W4315435880 hasConcept C535046627 @default.
• W4315435880 hasConcept C71924100 @default.
• W4315435880 hasConcept C77411442 @default.
• W4315435880 hasConcept C98274493 @default.
• W4315435880 hasConceptScore W4315435880C126322002 @default.
• W4315435880 hasConceptScore W4315435880C177713679 @default.
• W4315435880 hasConceptScore W4315435880C203092338 @default.
• W4315435880 hasConceptScore W4315435880C204243189 @default.
• W4315435880 hasConceptScore W4315435880C3018890749 @default.
• W4315435880 hasConceptScore W4315435880C535046627 @default.
• W4315435880 hasConceptScore W4315435880C71924100 @default.
• W4315435880 hasConceptScore W4315435880C77411442 @default.
• W4315435880 hasConceptScore W4315435880C98274493 @default.
• W4315435880 hasFunder F4320332382 @default.
• W4315435880 hasIssue "10" @default.
• W4315435880 hasLocation W43154358801 @default.
• W4315435880 hasLocation W43154358802 @default.
• W4315435880 hasOpenAccess W4315435880 @default.
• W4315435880 hasPrimaryLocation W43154358801 @default.
• W4315435880 hasRelatedWork W1573843750 @default.
• W4315435880 hasRelatedWork W2082673550 @default.
• W4315435880 hasRelatedWork W2115837083 @default.
• W4315435880 hasRelatedWork W2164310161 @default.
• W4315435880 hasRelatedWork W2416510479 @default.
• W4315435880 hasRelatedWork W2517659937 @default.
• W4315435880 hasRelatedWork W2894665084 @default.
• W4315435880 hasRelatedWork W3035278090 @default.
• W4315435880 hasRelatedWork W4235671009 @default.
• W4315435880 hasRelatedWork W4288392727 @default.
• W4315435880 hasVolume "76" @default.
• W4315435880 isParatext "false" @default.
• W4315435880 isRetracted "false" @default.
• W4315435880 workType "article" @default.